While most of the mutations in JMML have already been discovered and affect genes involved in cytokine signaling such as RAS/ERK and JAK/STAT pathways [7–11], the role of non-coding RNAs in this disease is still undefined. This evidence concerns the gene SOAT1 and juvenile myelomonocytic leukemia.